The Advance of the HSCT Evaluation at Single-Cell Scale --Review

Abstract

Hematopoietic stem cell transplantation (HSCT) is one of the effective options for the treatment of irradiation-induced injury on hematopoiesis, malignant hematological diseases, and numerous benign severe hematopathy. However, the cellular composition of the graft for HSCT, as well as the significant events of transplanted HSCs in receipients including HSC homing, engraftment, differentiation, remains to be further elucidated. In recent years, with advances in single-cell techniques, the hematopoiesis has been decoding at single cell scale. In addition, single-cell RNA sequencing (scRNA-seq) has been used in the evaluation of hematopoietic dynamics post HSCT, which may be helpful to improve HSCT protocols and clinical outcomes. Hence, the recent advances of evaluating HSCT at single cell scale and the directions worthy paying attention to in the field have been reviewed briefly.